Nang Kuang Pharmaceutical Co., Ltd.

1752

TW0001752004

Pharmaceuticals

End-of-day quote Taiwan S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
44.55 ^TWD	-0.11%		+1.02%	-16.42%

Mar. 26	Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 12	Nang Kuang Pharmaceutical Co., Ltd. Announces Changes in Chief Internal Auditor	CI

Nang Kuang Pharmaceutical Co., Ltd. Announces Resignation of Wen-Yung Tsai as Spokesperson, Financial Officer, Accounting Officer and Corporate Governance Officer

February 07, 2024 at 02:03 am EST

Nang Kuang Pharmaceutical Co., Ltd. announced the resignation of Wen-Yung Tsai/Director of Nang Kuang Pharmaceutical Co., Ltd., as spokesperson, financial officer, accounting officer and corporate governance officer. Effective date is February 7, 2024.

Latest news about Nang Kuang Pharmaceutical Co., Ltd.

Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
Nang Kuang Pharmaceutical Co., Ltd. Announces Changes in Chief Internal Auditor	Mar. 12	CI
Nang Kuang Pharmaceutical Co., Ltd. Appoints Pen-Sung Chen as Corporate Governance Officer	Mar. 08	CI
Nang Kuang Pharmaceutical Co., Ltd. Announces Resignation of Wen-Yung Tsai as Spokesperson, Financial Officer, Accounting Officer and Corporate Governance Officer	Feb. 07	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02	CI
Nang Kuang Pharmaceutical Co., Ltd.(TWSE:1752) added to S&P Global BMI Index	23-09-18	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-05	CI
Nang Kuang Pharmaceutical Co., Ltd. Appoints Wen-Yung Tsai as Corporate Governance Officer	22-11-04	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-02	CI
Nang Kuang Pharmaceutical Co., Ltd. Receives Final U.S. FDA Approval for Its ANDA	22-05-26	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-04	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-01	CI
Nang Kuang Pharmaceutical Co., Ltd.(TWSE:1752) added to Taiwan TAIEX Index	22-02-17	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-04	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended 31 March 2021	21-05-13	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-03	CI
Nang Kuang Pharmaceutical Co., Ltd. Receives U.S. Food and Drug Administration Tentative Approval for Abbreviated New Drug Application	21-01-27	CI
Nang Kuang Pharmaceutical Co., Ltd. Receives Final U.S. FDA Approval for its ANDA	20-12-17	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-08	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-07	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-07	CI
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-09	CI

Chart Nang Kuang Pharmaceutical Co., Ltd.

Duration

Period

Chart Nang Kuang Pharmaceutical Co., Ltd.

More charts

Company Profile

NANG KUANG PHARMACEUTICAL CO., LTD. is principally engaged in the manufacture, processing and trading of western medicine. The company main products include injections, sterile injections, powder injections, hard capsules, bare ingots, film ingots, casing ingots, granules and creams, among others. The Company is also engaged in the manufacture, processing and trading of medical equipment. The Company distributes its products within the domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

2024-06-17 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NANG KUANG PHARMACEUTICAL CO., LTD.	-16.42%	138M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals